Seeing Is Believing
Currently out of the existing stock ratings of David Stanton, 11 are a BUY (55%), 8 are a HOLD (40%), 1 are a SELL (5%).
Analyst David Stanton, currently employed at JEFFERIES, carries an average stock price target met ratio of 60% that have a potential upside of 24.38% achieved within 211 days.
David Stanton’s has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on MESO, Mesoblast Ltd at 25-Nov-2025.
Analyst best performing recommendations are on NU (NU HOLDINGS LTD).
The best stock recommendation documented was for NU (NU HOLDINGS LTD) at 6/22/2022. The price target of $3.75 was fulfilled within 8 days with a profit of $0.19 (4.82%) receiving and performance score of 6.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Aug-2024
$39
$24.92 (176.99%)
$24
1 months 7 days ago
(27-Aug-2026)
5/7 (71.43%)
$20.82 (114.52%)
253
Hold Since 25-Nov-2025
10 months 9 days ago
(25-Nov-2025)
2/2 (100%)
$-4.3 (-63.24%)
649
Hold Since 24-Sep-2024
$12
$-1.19 (-9.02%)
2 years 10 days ago
(24-Sep-2024)
2/2 (100%)
$4.73 (65.06%)
78
Buy Since 20-Feb-2020
2 years 1 months 5 days ago
(29-Aug-2024)
0/2 (0%)
$38.82 (540.67%)
Sell Since 11-Feb-2021
$3
$-11.08 (-78.69%)
$4
3 years 2 months ago
(04-Aug-2023)
6/6 (100%)
$-0.28 (-8.54%)
110
What Year was the first public recommendation made by David Stanton?